Suchergebnisse - "Talloen, Willem"

PubPharm (106)

1

Automated Spot Counting in Microbiology

enthalten in: IEEE/ACM transactions on computational biology and bioinformatics | 2023

von Lin, C. | Duan, Y. | Sargsyan, D. | +9

2

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study

enthalten in: Antiviral research | 2023

von Verbinnen, T. | Talloen, W. | Janssen, H. | +6

3

Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection

enthalten in: Gut | 2023

von Janssen, H. | Hou, J. | Asselah, T. | +16

4

Particle count estimation in dilution series experiments

enthalten in: Naval Research Logistics (NRL) | 2023

von Duan, Y. | Lin, C. | Sargsyan, D. | +7

5

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

6

Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir)

enthalten in: Clinical pharmacology in drug development | 2022

von Vandenbossche, J. | Yogaratnam, J. | Hillewaert, V. | +8

7

JNJ-73763989 pharmacokinetics and safety : Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B

enthalten in: Antiviral therapy | 2022

von Gane, E. | Yuen, M. | Kakuda, T. | +13

8

Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Gane, E. | Schwabe, C. | Berliba, E. | +12

9

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

enthalten in: The New England journal of medicine | 2022

von Sadoff, J. | Gray, G. | Vandebosch, A. | +127

10

Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir)

enthalten in: Clinical Pharmacology in Drug Development | 2022

von Vandenbossche, J. | Yogaratnam, J. | Hillewaert, V. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]